We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

125 hedge funds and large institutions have $1.4B invested in Ventyx Biosciences in 2022 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,551% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $98K

141% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 22

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

20% more funds holding

Funds holding: 104 → 125 (+21)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

1% less capital invested

Capital invested by funds: $1.41B → $1.4B (-$12.9M)

4.47% less ownership

Funds ownership: 79.74% → 75.27% (-4.5%)

Holders
125
Holders Change
+21
Holders Change %
+20.19%
% of All Funds
2.01%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
37
Increased
53
Reduced
22
Closed
16
Calls
$1.62M
Puts
$98K
Net Calls
+$1.52M
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$62.6M
2
APM
Avidity Partners Management
Texas
+$38.1M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$33.2M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$30.2M
5
TCM
TCG Crossover Management
California
+$23.3M

Top Sellers

Rank Fund Capital Flow
1
TP
Third Point
New York
-$98.1M
2
DGM
Darwin Global Management
Jersey
-$48.9M
3
VP
venBio Partners
California
-$45.9M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$34.5M
5
LGM
Logos Global Management
California
-$21.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$16.7M +$2.98M +100,452 +25%
JFG
27
Jefferies Financial Group
New York
$15.4M +$13.9M +470,026 New
Holocene Advisors
28
Holocene Advisors
New York
$13.7M +$12.4M +417,235 New
GPP
29
Great Point Partners
Connecticut
$13.1M +$3.87M +130,728 +48%
EC
30
EcoR1 Capital
California
$13.1M – – –
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$12.4M +$11.2M +379,300 New
MCMC
32
Matrix Capital Management Company
New Hampshire
$11M – – –
American Century Companies
33
American Century Companies
Missouri
$9.71M -$61.9K -2,090 -0.7%
AAA
34
Affinity Asset Advisors
New York
$7.89M +$2.09M +70,623 +42%
ACP
35
Acuta Capital Partners
California
$7.56M +$3.27M +110,500 +61%
Northern Trust
36
Northern Trust
Illinois
$7.08M +$952K +32,130 +17%
IHAM
37
Integral Health Asset Management
New York
$6.89M +$3.26M +110,000 +110%
Charles Schwab
38
Charles Schwab
California
$6.55M +$1.16M +39,311 +24%
N
39
Nuveen
North Carolina
$6.33M +$3.67M +123,882 +179%
SCM
40
Suvretta Capital Management
New York
$6.11M – – –
NCM
41
Nantahala Capital Management
Connecticut
$5.18M +$1.23M +41,400 +35%
HighTower Advisors
42
HighTower Advisors
Illinois
$5.01M +$3.88K +131 +0.1%
Walleye Capital
43
Walleye Capital
New York
$4.09M +$2.91M +98,392 +373%
WP
44
Woodline Partners
California
$3.94M -$256K -8,650 -7%
Morgan Stanley
45
Morgan Stanley
New York
$3.91M +$1.08M +36,449 +44%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$3.62M +$887K +29,942 +37%
Millennium Management
47
Millennium Management
New York
$3.56M +$2.62M +88,407 +436%
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$2.9M -$2.5M -84,371 -49%
MAP
49
Moody Aldrich Partners
Massachusetts
$2.6M +$2.35M +79,250 New
Two Sigma Investments
50
Two Sigma Investments
New York
$2.5M -$451K -15,226 -17%
1
2
3 4 5

VTYX Hedge Fund Activity: Q4 2022 in Review

125 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2022, worth a combined $1.4B — down 0.91% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new VTYX positions and 16 closed out — a net gain of 21 holders — while 53 added to existing stakes and 22 trimmed.

The largest buyer was Capital International Investors, opening a new position worth an estimated $62.6M. The largest seller was Third Point, cutting an estimated $98.1M.

  • 125 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2022, up from 104 in Q3 2022.
  • Funds reported $1.4B of Ventyx Biosciences stock for Q4 2022, down 0.91% quarter-over-quarter.
  • 37 funds opened new Ventyx Biosciences positions in Q4 2022 and 16 closed out, a net change of +21 holders.
  • The largest Ventyx Biosciences buyer in Q4 2022 was Capital International Investors, an estimated $62.6M added.
  • The largest Ventyx Biosciences seller in Q4 2022 was Third Point, an estimated $98.1M sold.

Based on aggregated 13F filings for Q4 2022.